Filana Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | -35.4% | +3.9% | -24.9% | |
| – | – | -38.6% | +5.3% | -28.4% | |
| – | – | -39.7% | +6.1% | -25.7% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | -71.7% | -79.0% | – | |
| – | – | +94.6% | -16.7% | +271.6% | |
| – | – | +101.0% | -17.2% | +273.1% | |
| – | – | +163.2% | -27.6% | -16.4% | |
| – | – | -39.6% | +6.0% | -48.9% | |
| – | – | – | – | – | |
| – | +2.0% | +4.3% | +11,014.2% | -99.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.